This inventor holds 1 USPTO granted patent. Top assignee: The University of Mississippi. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: John C Craig, Jr: Innovator in Hypoglycemic Compositions
Introduction
John C Craig, Jr. is a notable inventor based in Oxford, MS (US). He has made significant contributions to the field of pharmacology, particularly in the development of hypoglycemic compositions. His innovative work focuses on utilizing natural extracts to create therapeutic compounds aimed at reducing blood sugar levels.
Latest Patents
John C Craig, Jr. holds a patent for a hypoglycemic composition and method of use. This patent describes a compound prepared from the extract of Xanthium strumarium, commonly known as cockleburr. The compound is characterized by its white crystalline glycoside structure, with a decomposition point of 278-279 degrees Celsius and a molecular formula of C31H48O24S2. The aglycone portion of the molecule has a molecular formula of C19H28O4. The patent details the compound's infrared spectrum, nuclear magnetic resonance spectrum, and mass spectrum, highlighting its unique properties. The hypoglycemic composition is designed to be mixed with a non-toxic, pharmaceutically acceptable carrier, and the method of use includes various administration routes such as intravenously, orally, intraperitoneally, and intramuscularly.
Career Highlights
John C Craig, Jr. is affiliated with the University of Mississippi, where he conducts research and develops his innovative ideas. His work has led to advancements in the treatment of conditions related to blood sugar levels, showcasing his commitment to improving health outcomes through scientific research.
Collaborations
John collaborates with Carlton E Turner, contributing to the advancement of their shared research interests. Their partnership exemplifies the importance of teamwork in the field of innovation and invention.
Conclusion
John C Craig, Jr. is a distinguished inventor whose work in hypoglycemic compositions has the potential to make a significant impact on healthcare. His dedication to research and innovation continues to pave the way for new therapeutic solutions.